Publikationen

Petry, M., Palus, M., Leitzen, E., Mitterreiter, J. G., Huang, B., Kröger, A., Verjans, G. M. G. M., Baumgärtner, W., Rimmelzwaan, G. F., Růžek, D., Osterhaus, A., & Prajeeth, C. K. (2021). Immunity to TBEV related flaviviruses with reduced pathogenicity protects mice from disease but not from TBEV entry into the CNS. Vaccines, 9(3: 196). https://doi.org/10.3390/vaccines9030196
Details anzeigen

Ricke-Hoch, M., Stelling, E., Lasswitz, L., Gunesch, A. P., Kasten, M., Zapatero-Belinchón, F. J., Brogden, G., Gerold, G., Pietschmann, T., Montiel, V., Balligand, J.-L., Facciotti, F., Hirsch, E., Gausepohl, T., Elbahesh, H., Rimmelzwaan, G. F., Höfer, A., Kühnel, M. P., Jonigk, D., et al. (2021). Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS ONE, 16(8), Article e0255335. https://doi.org/10.1371/journal.pone.0255335
Details anzeigen

Vieira, M. C., Donato, C. M., Arevalo, P., Rimmelzwaan, G. F., Wood, T., Lopez, L., Huang, Q. S., Dhanasekaran, V., Koelle, K., & Cobey, S. (2021). Lineage-specific protection and immune imprinting shape the age distributions of influenza B cases. Nature Communications, 12, Article 4313. https://doi.org/10.1038/s41467-021-24566-y
Details anzeigen

Wilken, L., & Rimmelzwaan, G. F. (2021). Cytosolic retention if dengue virus antigens as a strategy to enhance the induction of antigen-specific T-cell responses. In Stiftung Tierärztliche Hochschule Hannover (ed.), 14th Graduate School Days: 19/20 November 2021 : University of Veterinary Medicine, Institute for Pathology. Abstract book (Zoo V 02). 14th Graduate School Days, Hannover, 19.-20.11.2021. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

van der Veldt, A. A. M., Oosting, S. F., Dingemans, A.-M. C., Fehrmann, R. S. N., GeurtsvanKessel, C., Jalving, M., Rimmelzwaan, G. F., Kvistborg, P., Blank, C. U., Smit, E. F., Lemmens, V. E. E. P., Hiltermann, T. J. N., Koopmans, M. P. G., Huckriede, A. L. W., Rots, N. Y., van Els, C. A. C. M., van Baarle, D., Haanen, J. B. A. G., & de Vries, E. G. E. (2021). COVID-19 vaccination: the VOICE for patients with cancer. Nature Medicine, 27(4), 568–569. https://doi.org/10.1038/s41591-021-01240-w
Details anzeigen

Beicht, J., Kubinski, M., Gerlach, T., & Rimmelzwaan, G. F. (2020). Influenza virus as a vaccine vector for Tick-Borne Encephalitis Virus (TBEV). In Stiftung Tierärztliche Hochschule Hannover (Ed.), 13th Graduate School Days: 20/21 November 2020 / Stiftung Tierärztliche Hochschule Hannover (Zoo P 16). Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Jansen, J. M., Saletti, G., & Rimmelzwaan, G. F. (2020). Analysis of immune evasion of influenza H1N1pdm09 viruses from recognition by virus-specific T cells. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 13th Graduate School Days: 20/21 November 2020 / Stiftung Tierärztliche Hochschule Hannover (Zoo V 06). Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Kubinski, M., Beicht, J., Gerlach, T., Volz, A., Sutter, G., & Rimmelzwaan, G. F. (2020). Tick-borne encephalitis virus: a quest for better vaccines against a virus on the rise. Vaccines, 8(3), Article 451. https://doi.org/10.3390/vaccines8030451
Details anzeigen

Meineke, R., Werlein, C., Kühnel, M., Jonigk, D., Rimmelzwaan, G. F., & Elbahesh, H. (2020). Differential susceptibility of pandemic H1N1 and seasonal H3N2 Influenza A viruses to clinically-approved small molecule kinase inhibitors. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 13th Graduate School Days: 20/21 November 2020 / Stiftung Tierärztliche Hochschule Hannover (Zoo V 05). Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Saletti, G., Gerlach, T., Jansen, J. M., Molle, A., Elbahesh, H., Ludlow, M., Li, W., Bosch, B.-J., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2020). Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63. Scientific Reports, 10: 21447. https://doi.org/10.1038/s41598-020-78506-9
Details anzeigen

Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Recombinant modified vaccinia virus Ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice. Vaccines, 11(4), Article 714. https://doi.org/10.3390/vaccines11040714
Details anzeigen

Wilken, L., Stelz, S., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Transient blockade of Type I Interferon signalling promotes replication of Dengue Virus strain D2Y98P in adult wild-type mice. Viruses, 15(4), Article 814. https://doi.org/10.3390/v15040814
Details anzeigen

Michaely, L. M., Schuwerk, L., Allnoch, L., Schön, K., Waltl, I., Larsen, P.-K., Pavlou, A., Prajeeth, C. K., Rimmelzwaan, G. F., Becker, S. C., Kalinke, U., Baumgärtner, W., & Gerhauser, I. (2022). Intact type I interferon receptor signaling prevents hepatocellular necrosis but not encephalitis in a dose-dependent manner in Rift Valley fever virus infected mice. International Journal of Molecular Sciences, 23(20), Article 12492. https://doi.org/10.3390/ijms232012492
Details anzeigen

Petry, M., Palus, M., Leitzen, E., Mitterreiter, J. G., Huang, B., Kröger, A., Verjans, G. M. G. M., Baumgärtner, W., Rimmelzwaan, G. F., Růžek, D., Osterhaus, A., & Prajeeth, C. K. (2021). Immunity to TBEV related flaviviruses with reduced pathogenicity protects mice from disease but not from TBEV entry into the CNS. Vaccines, 9(3: 196). https://doi.org/10.3390/vaccines9030196
Details anzeigen

Kronenberg, J., Pars, K., Brieskorn, M., Prajeeth, C. K., Heckers, S., Schwenkenbecher, P., Skripuletz, T., Pul, R., Pavlou, A., & Stangel, M. (2019). Fumaric acids directly influence gene expression of neuroprotective factors in rodent microglia. International Journal of Molecular Sciences, 20(2: 325). https://doi.org/10.3390/ijms20020325
Details anzeigen

Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
Details anzeigen

Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
Details anzeigen

Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
Details anzeigen

Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
Details anzeigen

Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
Details anzeigen